ZN-c3 + Gemcitabine in Pancreatic Cancer | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
ZN-c3 + Gemcitabine in Pancreatic Cancer	Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, endocrine system disorder, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, pancreas disorder, pancreatic ductal adenocarcinoma, pancreatic neoplasm	Active, not recruiting	Phase 2	2026-05-04		NCT06015659

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Brandon Huffman, MD	1
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc	4
Lustgarten Foundation	12
Stand Up To Cancer	20

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Dana Farber Cancer Institute	Boston	United States	300